Natixis Advisors L.P. Acquires 85,002 Shares of Cerner Co. (CERN)

Natixis Advisors L.P. raised its holdings in Cerner Co. (NASDAQ:CERN) by 11.4% during the 1st quarter, HoldingsChannel reports. The firm owned 827,744 shares of the company’s stock after purchasing an additional 85,002 shares during the quarter. Natixis Advisors L.P.’s holdings in Cerner were worth $48,009,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Resources Investment Advisors Inc. lifted its holdings in shares of Cerner by 1.6% in the fourth quarter. Resources Investment Advisors Inc. now owns 47,051 shares of the company’s stock valued at $3,171,000 after purchasing an additional 753 shares in the last quarter. Beese Fulmer Investment Management Inc. lifted its holdings in shares of Cerner by 3.7% in the fourth quarter. Beese Fulmer Investment Management Inc. now owns 24,835 shares of the company’s stock valued at $1,674,000 after purchasing an additional 876 shares in the last quarter. Sentry Investment Management LLC lifted its holdings in shares of Cerner by 4.0% in the first quarter. Sentry Investment Management LLC now owns 23,112 shares of the company’s stock valued at $1,340,000 after purchasing an additional 896 shares in the last quarter. Bbva Compass Bancshares Inc. lifted its holdings in shares of Cerner by 1.2% in the first quarter. Bbva Compass Bancshares Inc. now owns 80,849 shares of the company’s stock valued at $4,690,000 after purchasing an additional 924 shares in the last quarter. Finally, LS Investment Advisors LLC lifted its holdings in shares of Cerner by 7.5% in the fourth quarter. LS Investment Advisors LLC now owns 13,296 shares of the company’s stock valued at $896,000 after purchasing an additional 926 shares in the last quarter. 79.30% of the stock is currently owned by institutional investors.

In related news, Vice Chairman Clifford W. Illig sold 307,700 shares of the company’s stock in a transaction that occurred on Thursday, March 8th. The shares were sold at an average price of $64.52, for a total transaction of $19,852,804.00. Following the completion of the transaction, the insider now owns 1,229,719 shares of the company’s stock, valued at $79,341,469.88. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Vice Chairman Clifford W. Illig sold 3,000 shares of the company’s stock in a transaction that occurred on Monday, May 7th. The stock was sold at an average price of $58.32, for a total transaction of $174,960.00. Following the transaction, the insider now directly owns 1,229,719 shares of the company’s stock, valued at approximately $71,717,212.08. The disclosure for this sale can be found here. Insiders have sold 327,948 shares of company stock valued at $21,083,917 in the last ninety days. 4.71% of the stock is currently owned by company insiders.

Shares of Cerner opened at $59.47 on Thursday, MarketBeat.com reports. Cerner Co. has a one year low of $52.05 and a one year high of $73.86. The company has a quick ratio of 2.93, a current ratio of 2.95 and a debt-to-equity ratio of 0.09. The company has a market cap of $19.82 billion, a P/E ratio of 27.03, a P/E/G ratio of 1.88 and a beta of 0.96.

Cerner (NASDAQ:CERN) last issued its quarterly earnings results on Wednesday, May 2nd. The company reported $0.58 EPS for the quarter, hitting the consensus estimate of $0.58. Cerner had a net margin of 16.50% and a return on equity of 15.80%. The firm had revenue of $1.29 billion during the quarter, compared to analyst estimates of $1.34 billion. During the same quarter in the prior year, the business posted $0.59 earnings per share. Cerner’s revenue for the quarter was up 2.6% compared to the same quarter last year. research analysts anticipate that Cerner Co. will post 2.28 EPS for the current year.

Several brokerages have issued reports on CERN. SunTrust Banks reduced their price target on shares of Cerner from $68.00 to $2.82 and set a “hold” rating on the stock in a report on Wednesday, February 7th. Cantor Fitzgerald cut their price objective on shares of Cerner from $83.00 to $80.00 and set an “overweight” rating for the company in a research report on Wednesday, February 7th. Argus lowered shares of Cerner from a “buy” rating to a “hold” rating and boosted their price objective for the company from $54.49 to $64.65 in a research report on Tuesday, March 13th. BidaskClub lowered shares of Cerner from a “sell” rating to a “strong sell” rating in a research report on Thursday, March 15th. Finally, Canaccord Genuity cut their price objective on shares of Cerner from $73.00 to $64.00 and set a “buy” rating for the company in a research report on Thursday, May 3rd. One research analyst has rated the stock with a sell rating, ten have given a hold rating and eleven have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $68.51.

About Cerner

Cerner Corporation provides health care information technology solutions and services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.

Want to see what other hedge funds are holding CERN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cerner Co. (NASDAQ:CERN).

Institutional Ownership by Quarter for Cerner (NASDAQ:CERN)

Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply